Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
Miconazole  ||| S:10 E:21 ||| NNP
on  ||| S:21 E:24 ||| IN
[ ||| S:24 E:25 ||| -LRB-
Ca²⁺ ||| S:25 E:29 ||| NNP
] ||| S:29 E:30 ||| -RRB-
i  ||| S:30 E:32 ||| FW
and  ||| S:32 E:36 ||| CC
Cytotoxicity  ||| S:36 E:49 ||| NNP
in  ||| S:49 E:52 ||| IN
ZR-75-1  ||| S:52 E:60 ||| NNP
Human  ||| S:60 E:66 ||| NNP
Breast  ||| S:66 E:73 ||| NNP
Cancer  ||| S:73 E:80 ||| NNP
Cells  ||| S:80 E:86 ||| NNP
The  ||| S:86 E:90 ||| DT
effect  ||| S:90 E:97 ||| NN
of  ||| S:97 E:100 ||| IN
the  ||| S:100 E:104 ||| DT
antifungal  ||| S:104 E:115 ||| JJ
drug  ||| S:115 E:120 ||| NN
miconazole  ||| S:120 E:131 ||| NN
on  ||| S:131 E:134 ||| IN
Ca²⁺  ||| S:134 E:139 ||| CD
signaling  ||| S:139 E:149 ||| NN
in  ||| S:149 E:152 ||| IN
human  ||| S:152 E:158 ||| JJ
breast  ||| S:158 E:165 ||| NN
cancer  ||| S:165 E:172 ||| NN
cells  ||| S:172 E:178 ||| NNS
is  ||| S:178 E:181 ||| VBZ
unknown ||| S:181 E:188 ||| JJ
.  ||| S:188 E:190 ||| .
This  ||| S:190 E:195 ||| DT
study  ||| S:195 E:201 ||| NN
examined  ||| S:201 E:210 ||| VBD
the  ||| S:210 E:214 ||| DT
effect  ||| S:214 E:221 ||| NN
of  ||| S:221 E:224 ||| IN
miconazole  ||| S:224 E:235 ||| NN
on  ||| S:235 E:238 ||| IN
cytosolic  ||| S:238 E:248 ||| JJ
free  ||| S:248 E:253 ||| JJ
Ca²⁺  ||| S:253 E:258 ||| CD
concentrations  ||| S:258 E:273 ||| NNS
( ||| S:273 E:274 ||| -LRB-
[ ||| S:274 E:275 ||| -LRB-
Ca²⁺ ||| S:275 E:279 ||| NNP
] ||| S:279 E:280 ||| -RRB-
i ||| S:280 E:281 ||| FW
)  ||| S:281 E:283 ||| -RRB-
in  ||| S:283 E:286 ||| IN
ZR-75-1  ||| S:286 E:294 ||| CD
human  ||| S:294 E:300 ||| JJ
breast  ||| S:300 E:307 ||| NN
cancer  ||| S:307 E:314 ||| NN
cells ||| S:314 E:319 ||| NNS
.  ||| S:319 E:321 ||| .
The  ||| S:321 E:325 ||| DT
Ca²⁺-sensitive  ||| S:325 E:340 ||| FW
fluorescent  ||| S:340 E:352 ||| FW
dye  ||| S:352 E:356 ||| FW
fura-2  ||| S:356 E:363 ||| NNP
was  ||| S:363 E:367 ||| VBD
used  ||| S:367 E:372 ||| VBN
to  ||| S:372 E:375 ||| TO
measure  ||| S:375 E:383 ||| VB
[ ||| S:383 E:384 ||| -LRB-
Ca²⁺ ||| S:384 E:388 ||| NNP
] ||| S:388 E:389 ||| -RRB-
i ||| S:389 E:390 ||| FW
.  ||| S:390 E:392 ||| .
Miconazole  ||| S:392 E:403 ||| JJ
induced  ||| S:403 E:411 ||| NNS
[ ||| S:411 E:412 ||| -LRB-
Ca²⁺ ||| S:412 E:416 ||| NNP
] ||| S:416 E:417 ||| -RRB-
i  ||| S:417 E:419 ||| FW
rises  ||| S:419 E:425 ||| FW
concentration-dependently ||| S:425 E:450 ||| FW
.  ||| S:450 E:452 ||| .
The  ||| S:452 E:456 ||| DT
response  ||| S:456 E:465 ||| NN
was  ||| S:465 E:469 ||| VBD
reduced  ||| S:469 E:477 ||| VBN
by  ||| S:477 E:480 ||| IN
60 ||| S:480 E:482 ||| CD
%  ||| S:482 E:484 ||| NN
by  ||| S:484 E:487 ||| IN
removing  ||| S:487 E:496 ||| VBG
extracellular  ||| S:496 E:510 ||| JJ
Ca²⁺ ||| S:510 E:514 ||| NN
.  ||| S:514 E:516 ||| .
Miconazole-induced  ||| S:516 E:535 ||| NNP
Ca²⁺  ||| S:535 E:540 ||| NNP
entry  ||| S:540 E:546 ||| NN
was  ||| S:546 E:550 ||| VBD
abolished  ||| S:550 E:560 ||| VBN
by  ||| S:560 E:563 ||| IN
the  ||| S:563 E:567 ||| DT
protein  ||| S:567 E:575 ||| NN
kinase  ||| S:575 E:582 ||| VBD
C  ||| S:582 E:584 ||| NNP
( ||| S:584 E:585 ||| -LRB-
PKC ||| S:585 E:588 ||| NNP
)  ||| S:588 E:590 ||| -RRB-
inhibitor  ||| S:590 E:600 ||| FW
GF109203X ||| S:600 E:609 ||| FW
,  ||| S:609 E:611 ||| ,
and  ||| S:611 E:615 ||| CC
nifedipine ||| S:615 E:625 ||| NN
,  ||| S:625 E:627 ||| ,
but  ||| S:627 E:631 ||| CC
was  ||| S:631 E:635 ||| VBD
insensitive  ||| S:635 E:647 ||| VBN
to  ||| S:647 E:650 ||| TO
econazole ||| S:650 E:659 ||| VB
,  ||| S:659 E:661 ||| ,
SKF96365  ||| S:661 E:670 ||| NNP
and  ||| S:670 E:674 ||| CC
the  ||| S:674 E:678 ||| DT
protein  ||| S:678 E:686 ||| NN
kinase  ||| S:686 E:693 ||| VBD
C  ||| S:693 E:695 ||| $
activator  ||| S:695 E:705 ||| CD
phorbol  ||| S:705 E:713 ||| CD
12-myristate  ||| S:713 E:726 ||| CD
13  ||| S:726 E:729 ||| CD
acetate  ||| S:729 E:737 ||| NNS
( ||| S:737 E:738 ||| -LRB-
PMA ||| S:738 E:741 ||| NNP
) ||| S:741 E:742 ||| -RRB-
.  ||| S:742 E:744 ||| .
In  ||| S:744 E:747 ||| IN
Ca²⁺-free  ||| S:747 E:757 ||| CD
medium ||| S:757 E:763 ||| NN
,  ||| S:763 E:765 ||| ,
treatment  ||| S:765 E:775 ||| NN
with  ||| S:775 E:780 ||| IN
the  ||| S:780 E:784 ||| DT
endoplasmic  ||| S:784 E:796 ||| FW
reticulum  ||| S:796 E:806 ||| FW
Ca²⁺  ||| S:806 E:811 ||| FW
pump  ||| S:811 E:816 ||| FW
inhibitor  ||| S:816 E:826 ||| FW
2,5-di-tert-butylhydroquinone  ||| S:826 E:856 ||| FW
( ||| S:856 E:857 ||| -LRB-
BHQ ||| S:857 E:860 ||| NNP
)  ||| S:860 E:862 ||| -RRB-
or  ||| S:862 E:865 ||| CC
thapsigargin  ||| S:865 E:878 ||| NNS
( ||| S:878 E:879 ||| -LRB-
TG ||| S:879 E:881 ||| NNP
)  ||| S:881 E:883 ||| -RRB-
greatly  ||| S:883 E:891 ||| RB
inhibited  ||| S:891 E:901 ||| VBD
miconazole-evoked  ||| S:901 E:919 ||| JJ
[ ||| S:919 E:920 ||| -LRB-
Ca²⁺ ||| S:920 E:924 ||| NNP
] ||| S:924 E:925 ||| -RRB-
i  ||| S:925 E:927 ||| FW
rises ||| S:927 E:932 ||| FW
.  ||| S:932 E:934 ||| .
Conversely ||| S:934 E:944 ||| RB
,  ||| S:944 E:946 ||| ,
treatment  ||| S:946 E:956 ||| NN
with  ||| S:956 E:961 ||| IN
miconazole  ||| S:961 E:972 ||| NN
abolished  ||| S:972 E:982 ||| VBD
TG  ||| S:982 E:985 ||| NNP
and  ||| S:985 E:989 ||| CC
BHQ-evoked  ||| S:989 E:1000 ||| NNP
[ ||| S:1000 E:1001 ||| -LRB-
Ca²⁺ ||| S:1001 E:1005 ||| NNP
] ||| S:1005 E:1006 ||| -RRB-
i  ||| S:1006 E:1008 ||| FW
rises ||| S:1008 E:1013 ||| FW
.  ||| S:1013 E:1015 ||| .
Inhibition  ||| S:1015 E:1026 ||| NNP
of  ||| S:1026 E:1029 ||| IN
phospholipase  ||| S:1029 E:1043 ||| JJ
C  ||| S:1043 E:1045 ||| NNP
( ||| S:1045 E:1046 ||| -LRB-
PLC ||| S:1046 E:1049 ||| NNP
)  ||| S:1049 E:1051 ||| -RRB-
with  ||| S:1051 E:1056 ||| IN
U73122  ||| S:1056 E:1063 ||| NNP
abolished  ||| S:1063 E:1073 ||| VBD
miconazole-induced  ||| S:1073 E:1092 ||| JJ
[ ||| S:1092 E:1093 ||| -LRB-
Ca²⁺ ||| S:1093 E:1097 ||| NNP
] ||| S:1097 E:1098 ||| -RRB-
i  ||| S:1098 E:1100 ||| FW
rises ||| S:1100 E:1105 ||| FW
.  ||| S:1105 E:1107 ||| .
At  ||| S:1107 E:1110 ||| IN
concentrations  ||| S:1110 E:1125 ||| NNS
of  ||| S:1125 E:1128 ||| IN
30-50  ||| S:1128 E:1134 ||| NNP
μM ||| S:1134 E:1136 ||| NNP
,  ||| S:1136 E:1138 ||| ,
micronazole  ||| S:1138 E:1150 ||| VBD
killed  ||| S:1150 E:1157 ||| VBN
cells  ||| S:1157 E:1163 ||| NNS
in  ||| S:1163 E:1166 ||| IN
a  ||| S:1166 E:1168 ||| DT
concentration-dependent  ||| S:1168 E:1192 ||| JJ
manner ||| S:1192 E:1198 ||| NN
.  ||| S:1198 E:1200 ||| .
This  ||| S:1200 E:1205 ||| DT
cytotoxic  ||| S:1205 E:1215 ||| JJ
effect  ||| S:1215 E:1222 ||| NN
was  ||| S:1222 E:1226 ||| VBD
not  ||| S:1226 E:1230 ||| RB
reversed  ||| S:1230 E:1239 ||| VBN
by  ||| S:1239 E:1242 ||| IN
chelating  ||| S:1242 E:1252 ||| JJ
cytosolic  ||| S:1252 E:1262 ||| JJ
Ca²⁺  ||| S:1262 E:1267 ||| NN
with  ||| S:1267 E:1272 ||| IN
1,2-bis ||| S:1272 E:1279 ||| NNP
( ||| S:1279 E:1280 ||| -LRB-
2-aminophenoxy ||| S:1280 E:1294 ||| NNP
) ||| S:1294 E:1295 ||| -RRB-
ethane-N ||| S:1295 E:1303 ||| NNP
, ||| S:1303 E:1304 ||| ,
N ||| S:1304 E:1305 ||| NNP
, ||| S:1305 E:1306 ||| ,
N ||| S:1306 E:1307 ||| NNP
' ||| S:1307 E:1308 ||| POS
, ||| S:1308 E:1309 ||| ,
N ||| S:1309 E:1310 ||| NNP
' ||| S:1310 E:1311 ||| POS
-tetraacetic  ||| S:1311 E:1324 ||| JJ
acid ||| S:1324 E:1328 ||| FW
/ ||| S:1328 E:1329 ||| FW
acetoxy  ||| S:1329 E:1337 ||| FW
methyl  ||| S:1337 E:1344 ||| FW
( ||| S:1344 E:1345 ||| -LRB-
BAPTA ||| S:1345 E:1350 ||| NNP
/ ||| S:1350 E:1351 ||| NNP
AM ||| S:1351 E:1353 ||| NNP
) ||| S:1353 E:1354 ||| -RRB-
.  ||| S:1354 E:1356 ||| .
Together ||| S:1356 E:1364 ||| RB
,  ||| S:1364 E:1366 ||| ,
in  ||| S:1366 E:1369 ||| IN
ZR-75-1  ||| S:1369 E:1377 ||| CD
cells ||| S:1377 E:1382 ||| NNS
,  ||| S:1382 E:1384 ||| ,
miconazole  ||| S:1384 E:1395 ||| FW
induced  ||| S:1395 E:1403 ||| FW
[ ||| S:1403 E:1404 ||| -LRB-
Ca²⁺ ||| S:1404 E:1408 ||| NNP
] ||| S:1408 E:1409 ||| -RRB-
i  ||| S:1409 E:1411 ||| FW
rises  ||| S:1411 E:1417 ||| VBZ
by  ||| S:1417 E:1420 ||| IN
evoking  ||| S:1420 E:1428 ||| VBG
PLC-dependent  ||| S:1428 E:1442 ||| JJ
Ca²⁺  ||| S:1442 E:1447 ||| CD
release  ||| S:1447 E:1455 ||| NN
from  ||| S:1455 E:1460 ||| IN
the  ||| S:1460 E:1464 ||| DT
endoplasmic  ||| S:1464 E:1476 ||| JJ
reticulum ||| S:1476 E:1485 ||| NN
,  ||| S:1485 E:1487 ||| ,
and  ||| S:1487 E:1491 ||| CC
PKC-regulated  ||| S:1491 E:1505 ||| JJ
nifedipine-sensitive  ||| S:1505 E:1526 ||| JJ
Ca²⁺  ||| S:1526 E:1531 ||| CD
entry ||| S:1531 E:1536 ||| NN
.  ||| S:1536 E:1538 ||| .
Miconazole-caused  ||| S:1538 E:1556 ||| JJ
cell  ||| S:1556 E:1561 ||| NN
death  ||| S:1561 E:1567 ||| NN
was  ||| S:1567 E:1571 ||| VBD
not  ||| S:1571 E:1575 ||| RB
triggered  ||| S:1575 E:1585 ||| VBN
by  ||| S:1585 E:1588 ||| IN
a  ||| S:1588 E:1590 ||| DT
preceding  ||| S:1590 E:1600 ||| NN
[ ||| S:1600 E:1601 ||| -LRB-
Ca²⁺ ||| S:1601 E:1605 ||| NNP
] ||| S:1605 E:1606 ||| -RRB-
i  ||| S:1606 E:1608 ||| FW
rise ||| S:1608 E:1612 ||| NN
.  ||| S:1612 E:1614 ||| .
